García FP

Language: Spanish
References: 18
Page: 130-137
PDF size: 116.09 Kb.

ABSTRACT

For any type of cancer to appear, we consider that the cell should be excited; may the cell not be excitable, an electrochemical pathology will hardly be produced. The malignity of the cell is produced when high electric potentials and their consequent effects constantly act. Axon’s electric voltage is normaly 100 mV: cell excitability is due mainly to the size of its membrane, which oscillates between 50 mm and 80 mm of diameter. With a small diameter, its membrane will logically have less voltage activable ionic channels, and also less electrical capacity (capacitance); for this reason, it will contain a smaller amount of both positive and negative charges. Its axonic cone is of reduced size. So, it shows higher resistance to electricity: intracell axial diameter oscillates between 0’2 and 20 mm of diameter. If the diameter of the membrane is longer, it will have more axonal filaments and more number of positive and negative charges. And, finally, axons having longer diameter will facilitate the flowing of electric charges (Ohm’s law). As it is well known, with no stimulation, there is no conductibility; and, with no electricity, there are no chemical actions. Neoplasy will never occur when electricity is lower than the reobase: in this particular case, neuron - target connections remain inactive and unable to produce excitability.

REFERENCES

1. Tannenbaum A. The initiation and growth of tumours. Effect of underfeeding. Am J Cancer 1940;38:335-350.

2. Nelsens F, Pladziewicz JR. Intermolecular electron transfer reactivity determined from cross-rate studies. Accounts Chem Res 2002;35:247-254.

3. Iversen OH. The skin tumorigenic and carcinogenic effects of different doses, number of dose fractions and concentrations of 7,12-dimethylenz(a)anthracene in acetone applied on hairless mouse epidermis. Possible implications for human carcinogenesis. Carcinogenesis 1991:12,493-502.

4. Hennings H, Shores R, Wenk ML, Spangler EF, Tarone R, Yuspa SH. Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumours promoters. Nature 1983: 67-69,304.

5. Ribas B, García AO, Pérez CM, García FP. Some data on the comparison between the eukaryotic cell electric activity and the electromagnetic hypersensitivity syndrome. ELSAF, Wroclaw, Poland. 2001.

6. Ortuño OM. Física para Biología, Medicina, Veterinaria y Farmacia. 1ª ed.; editorial Hurope, S.L. Recared, 2. 08005-Barcelona. 1996:331,400-401.

7. Dale D. Electrocardiografía Práctica. 3ª Ed. Edit. McGraw-Hill Interamericana: 2000:8,9,23,73-74,76-77,153.

8. Morros SJ. Elementos de Fisiología. 8ª Ed.; Editorial Científico-Médica, 1961:071-1069.

9. García FP. Origen del Cáncer. Sin publicar 2003:18-19,22,24-27,32,36-39,43,47-49,99-101.

10. Testut-Latarjet. Anatomía Humana. Tomo 2; Editorial Slava Editores S.A. 1975.

11. Latarjet-Ruiz L. Anatomía Humana. Tomo 1, 3ª edición. Editorial Médica (Panamericana) 1999:199.

12. Walton SC. Curso Completo de Electricidad. 3ª ed. Editorial Bailliri, S.A. Madrid. 1941.

13. Timbie WH. Elementos de Electricidad. 3a Edición. Editorial Bailly Bailliere S.A., Madrid. 1941.

14. Kandel E, Jessell THM, Schwartz J. Neurociencia y Conducta. 2ª Ed. (J. Stummpf, ed.), Impr. Grafilles, Madrid: 1999:25,51,68,71-72,146,162,187-188.

15. González BM. Cáncer y medio ambiente. Edit. Noesis-Madrid. 1997:43,49,51,67.

16. Sodi PD. Magnetoterapia y cáncer. 2ª Edición. 1995:141,175,184-186,188-189,193-194,198.

17. Diccionario Oxford-Complutense. Física. 1ª Ed. Editorial Complutense, S.A. Madrid. 1998:434.

18. González BM. Oncología clínica. 2ª ed. Edit. Mono Comp. S.A.; 1998:16,370.